Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Inezetamab is a bispecific monoclonal antibody targeting CD40 and mesothelin (MSLN) designed to activate antigen-presenting cells and target mesothelin-expressing tumors. It is in Phase 1 clinical trials.
仅用于科研。不用于诊断过程。未经明确授权不得转售。